Trials / Completed
CompletedNCT06594224
Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Muhammad Aamir Latif · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The local data is insufficient to directly compare IV nalbuphine versus ibuprofen among people in this region. The findings of this study would add to the existing data and would be helpful for health providers to opt for a better option for postoperative pain relief following a cesarean section under general anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen | Patients were given 800 mg Ibuprofen in 200 cc normal saline intravenously at the time of arrival in the ward. |
| DRUG | Nalbuphine | Patients received 20 mg nalbuphine in 200 cc normal saline IV at the time of arrival in the ward. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
2 sites across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06594224. Inclusion in this directory is not an endorsement.